Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features

Central nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL) is associated with a poor prognosis. However, prophylactic measures, including intrathecal (IT) methotrexate, reduce the incidence of CNS relapse in these patients considerably. Unfortunately, IT methotrexate can cause severa...

Full description

Bibliographic Details
Main Authors: Hamza Tariq, Andrea Gilbert, Francis E Sharkey
Format: Article
Language:English
Published: SAGE Publishing 2018-11-01
Series:Clinical Medicine Insights: Pathology
Online Access:https://doi.org/10.1177/1179555718809071
_version_ 1819097490216976384
author Hamza Tariq
Andrea Gilbert
Francis E Sharkey
author_facet Hamza Tariq
Andrea Gilbert
Francis E Sharkey
author_sort Hamza Tariq
collection DOAJ
description Central nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL) is associated with a poor prognosis. However, prophylactic measures, including intrathecal (IT) methotrexate, reduce the incidence of CNS relapse in these patients considerably. Unfortunately, IT methotrexate can cause several neurologic complications, including transverse myelopathy; ie, the development of isolated spinal cord dysfunction over hours or days following the IT infusion of methotrexate, but in the absence of a compressive lesion. Transverse myelopathy following IT methotrexate is a well-established clinical phenomenon, but the histologic features have been described only very rarely. We report the autopsy findings from a 31-year-old man with a history of T-cell ALL who received prophylactic IT methotrexate in anticipation of a bone marrow transplant. Microscopic examination showed transverse necrosis of the thoracic cord, with massive infiltration by macrophages and lymphocytes, and perivascular lymphocytic infiltrates. There was cavitary necrosis of cervical and lumbar spinal cord involving the entire gray matter and focal white matter, as well as extensive subpial vacuolar degeneration of the dorsal and lateral columns.
first_indexed 2024-12-22T00:15:55Z
format Article
id doaj.art-c7302a627041489886b7e0104091675c
institution Directory Open Access Journal
issn 1179-5557
language English
last_indexed 2024-12-22T00:15:55Z
publishDate 2018-11-01
publisher SAGE Publishing
record_format Article
series Clinical Medicine Insights: Pathology
spelling doaj.art-c7302a627041489886b7e0104091675c2022-12-21T18:45:18ZengSAGE PublishingClinical Medicine Insights: Pathology1179-55572018-11-011110.1177/1179555718809071Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic FeaturesHamza TariqAndrea GilbertFrancis E SharkeyCentral nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL) is associated with a poor prognosis. However, prophylactic measures, including intrathecal (IT) methotrexate, reduce the incidence of CNS relapse in these patients considerably. Unfortunately, IT methotrexate can cause several neurologic complications, including transverse myelopathy; ie, the development of isolated spinal cord dysfunction over hours or days following the IT infusion of methotrexate, but in the absence of a compressive lesion. Transverse myelopathy following IT methotrexate is a well-established clinical phenomenon, but the histologic features have been described only very rarely. We report the autopsy findings from a 31-year-old man with a history of T-cell ALL who received prophylactic IT methotrexate in anticipation of a bone marrow transplant. Microscopic examination showed transverse necrosis of the thoracic cord, with massive infiltration by macrophages and lymphocytes, and perivascular lymphocytic infiltrates. There was cavitary necrosis of cervical and lumbar spinal cord involving the entire gray matter and focal white matter, as well as extensive subpial vacuolar degeneration of the dorsal and lateral columns.https://doi.org/10.1177/1179555718809071
spellingShingle Hamza Tariq
Andrea Gilbert
Francis E Sharkey
Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
Clinical Medicine Insights: Pathology
title Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
title_full Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
title_fullStr Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
title_full_unstemmed Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
title_short Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features
title_sort intrathecal methotrexate induced necrotizing myelopathy a case report and review of histologic features
url https://doi.org/10.1177/1179555718809071
work_keys_str_mv AT hamzatariq intrathecalmethotrexateinducednecrotizingmyelopathyacasereportandreviewofhistologicfeatures
AT andreagilbert intrathecalmethotrexateinducednecrotizingmyelopathyacasereportandreviewofhistologicfeatures
AT francisesharkey intrathecalmethotrexateinducednecrotizingmyelopathyacasereportandreviewofhistologicfeatures